CXXC5 (CXXC finger protein 5) by Yasar, P & Muyan, M
  
 
 
   
Gene Section 
Short Communication 
 
Atlas Genet Cytogenet Oncol Haematol. 2014; 19(1) 1 
Atlas of Genetics and Cytogenetics 
in Oncology and Haematology 
INIST-CNRS 
 
OPEN ACCESS JOURNAL 
 
CXXC5 (CXXC finger protein 5) 
Pelin Yasar, Mesut Muyan 
Department of Biological Sciences, Middle East Technical University, Ankara, Turkey (PY, MM) 
 
Published in Atlas Database: April 2014 
Online updated version : http://AtlasGeneticsOncology.org/Genes/CXXC5ID52549ch5q31.html 
DOI: 10.4267/2042/55369 
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. 
© 2015 Atlas of Genetics and Cytogenetics in Oncology and Haematology 
 
Abstract 
Review on CXXC5, with data on DNA/RNA, on 
the protein encoded and where the gene is 
implicated. 
Identity 
Other names: CF5, RINF, WID 
HGNC (Hugo): CXXC5 
Location: 5q31.2 
Local order: From centromere to telomere: 
SPATA24-DNAJC18-ECSCR-TMEM173-
UBE2D2-CXXC5-PSD2-NRG2. 
Note: Orientation on forward strand. 
DNA/RNA 
Description 
The gene is on the plus strand and encompasses 35 
kb of DNA.  
The exon number of gene is 3 and parts of the 
second and third exons encode the protein 
(ENSP00000302543). 
Transcription 
1447 bp long mRNA; 969 bp long open reading 
frame. 
Pseudogene 
No reported pseudogenes. 
 
Local order of CXXC5 is shown together with leading and subsequent genes on chromosome 5. The direction of arrows indicates 
transcriptional directions on the chromosome and arrow sizes approximate gene sizes. 
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Boxes are exons. The lines are introns. Shaded parts of the exon boxes are coding regions. Unshaded parts are noncoding 
regions. 
 
CXXC5 contains a nuclear localization signal adjacent to the CXXC-zinc finger domain. 
 
Protein 
Description 
CXXC5 encodes a 322 amino-acid protein with a 
molecular mass of 33 kDa. Amino-acid sequence 
suggests that CXXC5 contains a number of 
phosphorylation and acetylation sites.  
By homology, CXXC5 is considered to be a 
member of CXXC-type zinc finger protein family, 
which binds to non-methylated CpG dinuclotide 
containing DNA. 
Expression 
CXXC5 is expressed in various tissues. 
Localisation 
CXXC5 protein is mainly in the nucleus. CXXC5 
protein may also be localized in the cytoplasm 
coupled with Dishevelled (Dvl) protein (Andersson 
et al., 2009). 
Function 
CXXC5 can be induced by retinoid signaling and is 
required for myelopoiesis (Pendino et al., 2009). 
CXXC5 protein is involved in the DNA-damage 
induced p53 activation as well as in the regulation 
of cell cycle and apoptosis (Zhang et al., 2009). 
CXXC5 protein participates in the TNF-a-induced 
apoptosis through association with SMAD (Wang 
et al., 2013).  
CXXC5 protein is a critical modulator of BMP4-
regulated Wnt-signaling in neural stem cells 
(Andersson et al., 2009).  
CXXC5 protein is shown to repress TET2 gene 
expression (Ko et al., 2013). 
Homology 
CXXC domain is a highly conserved domain of a 
class of proteins that interact with non-methylated 
CpG dinucleotides (CpGs). The CXXC domain of 
CXXC5 displays a significant homology to CXXC 
domains of CXXC4 and TET3 proteins (Ko et al., 
2013). 
Mutations 
Note 
Not defined yet. 
Implicated in 
Acute myeloid leukemia (AML) and 
Myelodysplastic syndrome (MDS) 
Disease 
Acute myeloid leukemia (AML) is a disease 
manifested by cytogenetic anomalies affecting cell 
proliferation, death and differentiation (Renneville 
et al., 2008). Myelodysplastic syndrome (MDS) 
defines a hematological condition with insufficient 
hematopoiesis. MDS results from chromosomal 
deletions, inversions and translocations giving rise 
to trilineage dysplasia (Mhawech and Saleem, 
2001). 
Oncogenesis 
The region on the chromosome 5 which also 
contains CXXC5 gene (5q31.2) is often deleted in 
AML and MDS (Treppendahl et al., 2013). Low 
survival rate has been observed in intensive 
chemotherapy treated patients with AML who show 
a high level of CXXC5 gene expression (Astori et 
al., 2013). 
Acute promyelocytic leukemia (APL) 
Disease 
APL, which is characterized by the translocation 
event of the retinoic acid receptor alpha gene, is a 
rare subtype of AML in which leukemia cells are 
sensitive to anthracyclines (Tallman and Altman, 
2008). 
Oncogenesis 
Terminal maturation of premyelocytic leukemia 
cells requires the expression of CXXC5 (Pendino et 
al., 2009). 
Breast cancer 
Disease 
Breast cancer is a disease which is mainly 
originated in the lining of the milk ducts and/or the 
lobules. 
Oncogenesis 
It has been shown that CXXC5 is transcriptionally 
upregulated in some solid tumors including 
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melanoma, thyroid and breast cancer. In addition, 
overexpression of CXXC5 in breast cancer is 
suggested to be associated with poor prognosis 
(Knappskog et al., 2011). 
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